Johnson & Johnson and Royalty Pharma Enter USD 500 Million R&D Co-funding Agreement

Marco Zingaro Europe Legal Chronicle
Tagged:

Pestalozzi and Ropes & Gray LLP have advised Johnson & Johnson. Goodwin Procter LLP has advised Royalty Pharma. On March 30, 2026, Royalty Pharma plc and…

Membership Required

You must be a member to access this content.

View Membership Levels

Already a member? Log in here
  Share:

Author: Marco Zingaro

…

Membership Required

You must be a member to access this content.

View Membership Levels

Already a member? Log in here